Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
09997 KANGJI MEDICAL
RT Nominal unchange5.980 0.000 (0.000%)
Latest  |  Final  |  Interim
Non-current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others220,87430.679%169,02087,58563,25156,526
Land & other Lease Assets64,904-34.816%99,57119,79621,57117,024
Intangible Assets451,903-0.004%451,9211193366
Interests in Asso. & JCEs0--0000
Other Non-current Assets145,4483.419%140,639114,4545,3791,901

883,1292.552%861,151221,95490,23475,517
Current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Inventories105,205-0.184%105,39968,37651,44236,922
Trade Receivables225,53438.241%163,14581,11987,40773,012
Cash & Bank Balances2,676,588-5.030%2,818,3602,953,6592,232,046565,148
Other Current Assets21,160-42.587%36,85665,236559,13242,183
Assets Held for Sale352,202--0000

3,380,6898.225%3,123,7603,168,3902,930,027717,265
Current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Trade Payables34,14664.543%20,75218,26111,4079,318
S-T Debt & Leases6,107-8.796%6,6961,6951,4650
Other Current Liabilities145,93115.615%126,22196,61662,574258,054
Liab asso w/ Assets Held for Sale4,640--0000

190,82424.179%153,669116,57275,446267,372
Net Current Assets3,189,8657.400%2,970,0913,051,8182,854,581449,893
Total Assets Less Current Liabilities4,072,9946.310%3,831,2423,273,7722,944,815525,410
Non-current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
L-T Debt & Leases37,883-10.491%42,3232,3513,5850
Other Non-current Liabilities91,26530.172%70,11111,0204,6199,950

129,14814.866%112,43413,3718,2049,950
Capital and Reserves
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
  Share Capital860.000%8688880
  Reserves3,649,6768.205%3,372,9123,260,3132,936,523327,228
  Others0--0000
Shareholders' Funds3,649,7628.205%3,372,9983,260,4012,936,611327,228
Non-controlling Interests294,084-14.958%345,81000188,232
Others0--0000

3,943,8466.051%3,718,8083,260,4012,936,611515,460
Commitments and Contingent Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Commitments45,792-33.140%68,4898982,379114
Contingent Liabilities0--0000
Remarks:  Real time quote last updated: 06/11/2024 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (¥)RMB 285,847,000
%Change11.895%
EPS / (LPS)RMB 0.244
NBV Per Share (¥)RMB 1.945
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.